Insider filing · PGEN
Randal J Kirk
Director
profile →
Precigen, Inc.
PGEN · Healthcare · 21 filings in 24 months
ticker →
Randal J Kirk sold $15.7M of Precigen (PGEN)
Executed Mar 30, disclosed Mar 31, 1 day later.
Value, as filed
$15.7M
4,748,992 sh across 10 lots
Executed
Mar 30
the trade date, as filed
Disclosed
Mar 31
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RKRandal J Kirk (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Precigen, Inc. (PGEN). The largest single filing was $15.7M of PGEN (4,748,992 sh across 10 lots, as filed), executed Mar 30.
The name
PGENHealthcare · Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to tar…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Randal J Kirk in PGEN
PGENSALE
Precigen, Inc.
$7.7M1,846,412 sh across 6 lots
Exec Dec 22 2025
Filed Dec 22 2025 · 5:30 PM ET PGENSALE Precigen, Inc. $12.3M
2,966,293 sh across 3 lots
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET PGENSALE Precigen, Inc. $6.2M
1,809,667 sh × $3.41
Exec Sep 30 2025
Filed Sep 30 2025 · 5:30 PM ET PGENSALE Precigen, Inc. $18.7M
5,000,252 sh across 2 lots
Exec Sep 18 2025
Filed Sep 19 2025 · 5:30 PM ET